Nearly Four Million Medicare Beneficiaries Met the Eligibility Criteria in 2023 for the Medicare GLP-1 Bridge

• by Juliette Cubanski, Nolan Sroczynski

• June 29, 2026

ACP Suggests First-Line Obesity Drugs

Semaglutide and tirzepatide had the greatest net benefit among evaluated treatments, the committee concluded.

• by Kathryn Wighton

• June 16, 2026

• 5 min

Preoperative Use of a Mobile Application Within the Multidisciplinary Team Approach – A Randomized Controlled Clinical Trial

• by Celine Kadesch, Christel Weiss, Michael Hetjens, Niki Taebi, Sebastian Schölch, Christoph Reissfelder, Susanne Blank, Mirko Otto, Cui Yang

• June 15, 2026

Innovative models to explore hepatic involvement in Prader-Willi syndrome

• by Romar Guintu Dabban, Graziano Grugni, Adele Bondesan, Benedetta Blarasin, Claudio Tiribelli, Cristina Bellarosa, Alessandro Sartorio

• June 24, 2026